Qube Research & Technologies (QRT)’s Medtronic MDT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.2M	Sell	140,500 -12,500	-8%	-$1.2M	0.01%	1167
2025 Q4	$14.7M	Sell	153,000 -23,200	-13%	-$2.25M	0.01%	1090
2025 Q3	$16.8M	Sell	176,200 -207,000	-54%	-$19M	0.02%	990
2025 Q2	$33.4M	Buy	383,200 +118,500	+45%	+$10M	0.03%	629
2025 Q1	$23.8M	Buy	264,700 +192,200	+265%	+$17.2M	0.03%	675
2024 Q4	$5.79M	Sell	72,500 -86,200	-54%	-$7.46M	0.01%	1412
2024 Q3	$14.3M	Sell	158,700 -16,000	-9%	-$1.35M	0.02%	828
2024 Q2	$13.8M	Buy	174,700 +64,900	+59%	+$5.32M	0.02%	780
2024 Q1	$9.57M	Sell	109,800 -65,000	-37%	-$5.55M	0.02%	873
2023 Q4	$14.4M	Buy	174,800 +74,800	+75%	+$5.7M	0.03%	610
2023 Q3	$7.84M	Hold	100,000	–	–	0.02%	735
2023 Q2	$8.81M	Buy	+100,000	New	+$8.61M	0.03%	568

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MDT Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Medtronic (MDT) stake by 95% in Q1 2026, selling an estimated $139M and leaving 76,485 shares worth $6.63M. The position accounts for 0.01% of the portfolio, ranked #1523.

Qube Research & Technologies (QRT) first reported a position in MDT in Q1 2018 and has held it in 29 quarters since. The position peaked at $274M in Q4 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Qube Research & Technologies (QRT) held 76,485 shares of Medtronic worth $6.63M as of Q1 2026.
Qube Research & Technologies (QRT) sold 1,450,653 Medtronic shares in Q1 2026, an estimated $139M.
Medtronic made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1523 holding.
Qube Research & Technologies (QRT) first reported a position in Medtronic in Q1 2018 and has held it in 29 quarters since.
Qube Research & Technologies (QRT)'s Medtronic position peaked at $274M in Q4 2024.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.